摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,41-teramethoxy-40,42-dihydroxycalix<6>arene | 154388-73-5

中文名称
——
中文别名
——
英文名称
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,41-teramethoxy-40,42-dihydroxycalix<6>arene
英文别名
5,11,17,23,29,35-hexa-tert-butyl-37,38,39,41-tetramethoxycalix<6>arene-40,42-diol;5,11,17,23,29,35-hexa-tert-butyl-37,38,39,41-tetramethoxy-40,42-dihydroxycalix<6>arene;5,11,17,23,29,35-Hexatert-butyl-38,40,41,42-tetramethoxyheptacyclo[31.3.1.13,7.19,13.115,19.121,25.127,31]dotetraconta-1(36),3(42),4,6,9,11,13(41),15,17,19(40),21,23,25(39),27(38),28,30,33(37),34-octadecaene-37,39-diol
5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,41-teramethoxy-40,42-dihydroxycalix<6>arene化学式
CAS
154388-73-5
化学式
C70H92O6
mdl
——
分子量
1029.5
InChiKey
XZBMRLLAYRRXRS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    938.2±65.0 °C(Predicted)
  • 密度:
    1.038±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    20.7
  • 重原子数:
    76
  • 可旋转键数:
    10
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.49
  • 拓扑面积:
    77.4
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,41-teramethoxy-40,42-dihydroxycalix<6>arene叔丁基异氰酸酯 在 barium(II) hydroxide 作用下, 以 二氯甲烷 为溶剂, 反应 48.5h, 以99%的产率得到p-tert-butylcalix[6]arene-1,2,3,5-tetramethyl-3-mono-N-tert-butylaminocarbonyl
    参考文献:
    名称:
    基于多酚的分子平台的定制功能化
    摘要:
    选择性修饰大环低聚物的通用且有效的方法很少见,主要是因为难以将反应限制在一定数量的相同官能团上。这项工作描述了由多酚平台iteroselective官能一个独特的,一般情况下,合理的方法ñ -叔-butylaminocarbonyl(BAC)组。该方法包括使低聚平台与t反应-BuNCO和非极性溶剂中的无机碱。此非常简单的一步步骤已应用于各种杯[4、5、6和8]芳烃,并且在所有情况下,均以高收率(> 90%)分离了具有单个剩余酚部分的杯芳烃。有趣的是,这种所谓的“一劳永逸”的方法可以直接访问具有固有手性的杯芳烃。还显示了Bac基团可以用作保护基团。因此,仅用一种方法已用于关键前体平台的有效单功能化,说明了其用于复杂大环低聚物定制合成的巨大潜力。
    DOI:
    10.1021/jo501021c
  • 作为产物:
    描述:
    1,3,5-trimethoxy-p-tert-butylcalix[6]arene碘甲烷potassium carbonate 作用下, 以 丙酮 为溶剂, 反应 48.0h, 以39%的产率得到5,11,17,23,29,35-Hexa-tert-butyl-37,38,39,41-teramethoxy-40,42-dihydroxycalix<6>arene
    参考文献:
    名称:
    Syntheses of All Possible O-Methylation Products Derivable from 5,11,17,23,29,35-Hexa-tert-butylcalix[6]arene-37,38,39,40,41,42-hexol
    摘要:
    We here report methods for the synthesis of all twelve possible 0-methylation products from 5,11,17,23,29,35-hexa-tert-butylcalix[6]arene-37,38,39,40,41,42-hexol (1): one mono-, three di-, three tri-, three tetra-, one penta-, and one hexamethylated products. The strategies used are (i) direct O-methylation with different 1/K2CO3 ratios, (ii) selective mono-O-methylation of O-alkylation products, (iii) demethylation with TiCl4 or LiI, and (iv) protection-deprotection with a benzyl group or an o- or m-xylenyl group. We believe that these O-methylation products are useful as basic skeletons to design functionalized calix[6]arenes with the desired number of substituents and regioselectively-positioned functional groups.
    DOI:
    10.1021/jo00085a048
点击查看最新优质反应信息

文献信息

  • Definitive Evidence for Inhibition of Calix[6]arene Ring Inversion Obtained from a 1,3-Xylenyl-Bridged Chiral Calix[6]arene
    作者:Hideyuki Otsuka、Seiji Shinkai
    DOI:10.1021/ja953626b
    日期:1996.1.1
    To design calix[6]arene-based receptor molecules which show high affinity and high selectivity toward guest molecules, the construction of more rigid and conformationally-defined analogs has been l...
    为了设计对客体分子显示出高亲和力和高选择性的基于杯[6]芳烃的受体分子,构建更刚性和构象定义的类似物已成为一项重要...
  • Synthesis and NMR Spectroscopic Studies of Bridged and Capped Calix[6]arenes: High-Yield Syntheses of Unimolecular Caged Compounds from Calix[6]arene
    作者:Hideyuki Otsuka、Koji Araki、Hitoshi Matsumoto、Takaaki Harada、Seiji Shinkai
    DOI:10.1021/jo00120a033
    日期:1995.7
    Calix[6]arenes were bridged with a xylenyl unit or capped with a mesitylenyl unit, and their conformational properties were examined by spectroscopic methods. As previously reported by Gutsche et al., the calix[6]arene bridged on 1,4-phenyl units could enjoy slow ring inversion. The calix[6]arene bridged on 1,a-phenyl units also showed the ring inversion behavior, whereas in the calix[6]arene bridged on 1,3-phenyl units, ring inversion was virtually suppressed because of destabilization of the transition state. The capping of 1,3,5-tri-O-alkylated calix[6]arenes with 1,3,5-tris(bromomethyl)benzene gave the products in high yields (80-91%). This advantage was accounted for by the C-3 symmetrical complementarity of these two reactants. In these capped products, ring inversion was inhibited under the present measurement conditions, and the presence of a unimolecularly closed inner cavity was suggested on the basis of H-1 NMR spectroscopy and MM3 calculations.
  • Otsuka Hideyuki, Araki Koji, Shinkai Seiji, J. Org. Chem, 59 (1994) N 6, S 1542-1547
    作者:Otsuka Hideyuki, Araki Koji, Shinkai Seiji
    DOI:——
    日期:——
  • Syntheses of all poasible calix[6]arene derivatives with MeO- and ROCOCH2O- substituents and their metal binding properties
    作者:Hideyuki Otsuka、Koji Araki、Seiji Shinkai
    DOI:10.1016/0040-4020(95)00466-l
    日期:1995.8
    It has become possible to synthesize all possible calix[6]arene derivatives with MeO- and ROCOCH(2)O- substituents from corresponding O-methylated calix[6]arenes(2-7). The yields of these reactions were relatively high and the products could be easily purified because of the absence of other regioisomers. They are one mono-, three di-, three tri-, three tetra-, one penta-, and one hexa-EtOCOCH(2)O-substituted products. It was proved that O-methylation products act as useful basic skeletons to design functionalized calix[6]arenes with the desired number of ROCOCH(2)O substituents and the regioselectively-positioned ROCOCH(2)O groups.
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯